IPO: Retension Pharmaceuticals, Inc.

Get ready for the highly anticipated IPO of Retension Pharmaceuticals, Inc. on NASDAQ Capital, set for Friday, October 9, 2026. As the countdown timer ticks down to this momentous event, investors and market enthusiasts alike are eager to see how RTSN will make its mark in the financial landscape. With a price range of $11.00 to $13.00, this IPO promises to attract attention and set the stage for exciting opportunities in the biotech sector. Stay tuned as we approach the launch, and keep an eye on our countdown timer to ensure you don't miss out on your chance to be part of this promising venture. Mark your calendars and prepare for an event that could shape the future of Retension Pharmaceuticals!